SCHEMBL2874877

SCHEMBL2874877

c1ccc(C(SOSC(c2ccccc2)c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.43
SLC6A3 Q01959 2/20 0.43
CYP2D6 P10635 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
SLC6A4 P31645 1/20 0.43
CYP2C19 P33261 1/20 0.43
DPP4 P27487 2/20 0.39
F2 P00734 1/20 0.39
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HTR2A P28223 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
SRC P12931 1/20 0.35
HRH1 P35367 1/20 0.33
MTOR P42345 1/20 0.33
RAB9A P51151 1/20 0.33
GRM7 Q14831 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10743810 0.89 LMNA (0.42) TSHRSLC6A3CYP2D6CYP1A2CYP3A4
SCHEMBL9561869 0.87 IDO1 (0.50) TSHRSLC6A3CYP2D6CYP1A2CYP3A4
SCHEMBL28768584 0.80 SLC6A4 (0.39) TSHRSLC6A3CYP2D6CYP1A2CYP3A4
SCHEMBL10734256 0.76 ALDH1A1 (0.46) TSHRCYP1A2CYP2C9SLC6A4CYP2C19
SCHEMBL913100 0.74 KMT2A (0.41) TSHRSLC6A3CYP2D6CYP1A2CYP3A4
SCHEMBL28511593 0.74 DPP4 (0.36) TSHRSLC6A3CYP2D6CYP1A2CYP3A4
SCHEMBL8823993 0.74 DPP4 (0.36) TSHRSLC6A3CYP2D6CYP1A2CYP3A4
SCHEMBL11132156 0.74 DPP4 (0.48) DPP4F2HTR2ATAAR1
SCHEMBL3718532 0.74 LMNA (0.41) TSHRCYP2D6L3MBTL1SRC
SCHEMBL4054070 0.74 CYP2D6 (0.38) TSHRSLC6A3CYP2D6CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104530417-B A kind of multiple functionalized H types polyethyleneglycol derivative and preparation method thereof 厦门赛诺邦格生物科技股份有限公司 2017-09-08 CN claimed
CN-104530415-B A kind of different functionalization Y types polyethyleneglycol derivative, preparation method and its bio-related substance 厦门赛诺邦格生物科技股份有限公司 2017-09-01 CN claimed
CN-104530415-A Hetero-functionalized Y-type polyethylene glycol derivative, preparation method and biologically related substance thereof XIAMEN SINOPEG BIOTECH INC 2015-04-22 CN claimed
CN-104530417-A Multifunctional H-type polyethylene glycol derivative and preparation method thereof XIAMEN SINOPEG BIOTECH INC 2015-04-22 CN claimed
CN-104109235-A Mono-functionalized polyethylene glycol with nitrogen atom branched center and its preparation method and biologically-relevant matter XIAMEN SINOPEG BIOTECH CO LTD 2014-10-22 CN claimed
CN-101550044-B Application of polyoxometalate/silicon dioxide catalyst in controllable oxidization of sulfide UNIV JILIN 2012-11-14 CN claimed
CN-101550044-A Application of polyoxometalate/silicon dioxide catalyst in controllable oxidization of sulfide UNIV JILIN (CN) 2009-10-07 CN claimed
US-11324827-B2 Multifunctionalized polyethylene glycol derivative and preparation method therefor XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2022-05-10 US disclosed
CN-110256307-A A method of synthesis sulfoxide compound 南京雷正医药科技有限公司 2019-09-20 CN disclosed
CN-108091826-A Nonaqueous electrolyte solution for secondary battery and nonaqueous electrolyte secondary battery using same 三菱化学株式会社 2018-05-29 CN disclosed
CN-108054283-A A kind of insensitive molybdenum trioxide anode interface layer of film thickness and preparation method thereof and the application in organic solar batteries 中国科学院化学研究所 2018-05-18 CN disclosed
CN-104725628-B A kind of single functionalization branched polyethylene glycol, preparation method and its bio-related substance containing degradable group 厦门赛诺邦格生物科技股份有限公司 2018-04-17 CN disclosed
US-20170312363-A1 MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2017-11-02 US disclosed
WO-2000078726-A1 IMIDAZOLINE DERIVATIVES FOR THE TREATMENT OF DIABETES, ESPECIALLY TYPE II DIABETES ELI LILLY AND COMPANY (US) 2000-12-28 WO disclosed
WO-2000078725-A1 SYNTHESIS OF SUBSTITUTED AMIDINES ELI LILLY AND COMPANY (US) 2000-12-28 WO disclosed
EP-1018984-A1 MEDICAL DEVICE FOR $i(IN VIVO) NITRIC OXIDE RELEASE Cordis Corporation (US) 2000-07-19 EP disclosed
WO-1999000070-A1 MEDICAL DEVICE FOR IN VIVO NITRIC OXIDE RELEASE CORDIS CORPORATION (US) 1999-01-07 WO disclosed
US-3971627-A MODIFIED POLYESTER, POLYAMIDE, POLYCARBONATE, POLYOLEFIN OR RAYON TIRE CORD HERCULES INCORPORATED (US) 1976-07-27 US disclosed
US-3971743-A CROSSLINKING POLYMERS HERCULES INCORPORATED (US) 1976-07-27 US disclosed
US-3941751-A Epoxy-azido compounds HERCULES INCORPORATED (US) 1976-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11324827-B2 Multifunctionalized polyethylene glycol derivative and preparation method therefor HDGF, F11, F12 TSHR 1973/4885SLC6A3 4728/4885CYP2D6 3820/4885
US-20170312363-A1 MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR HDGF, F11, F12 TSHR 1973/4885SLC6A3 4728/4885CYP2D6 3820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.